Health, Wellness & Beauty

SHERIDAN, WYOMING – November 9, 2024 – In a significant advancement for healthcare diagnostics, bioMérieux, a world leader in in vitro diagnostics, announces the launch of VIDAS® VITAMIN B12 TOTAL, a groundbreaking automated test designed to revolutionize the detection and management of vitamin B12 deficiency. This innovative test, which received CE marking, offers a rapid and efficient method for measuring vitamin B12 concentration in human serum or plasma, providing healthcare professionals with a critical tool for accurate diagnosis and timely treatment.

SHERIDAN, WYOMING – November 9, 2024 – SHERIDAN, WYOMING – November 9, 2024 – Alcon, a global leader in eye care dedicated to helping people see brilliantly, presented its latest innovations and clinical data at the American Academy of Ophthalmology (AAO) 2024 annual meeting. The company showcased advancements in glaucoma therapy, retina surgery, and dry eye treatment, demonstrating its commitment to improving patient outcomes and streamlining surgical workflows.

Voyager™ DSLT: Revolutionizing Glaucoma Treatment

Alcon's latest innovation for glaucoma therapy, the Voyager™ Direct Selective Laser Trabeculoplasty (DSLT) device, was a highlight of the event. This groundbreaking technology offers a first-line treatment option for glaucoma patients, eliminating the need for a gonio lens or manual aiming required for traditional Selective Laser Trabeculoplasty (SLT).

SHERIDAN, WYOMING – November 8, 2024 – Sanofi, a leading global biopharmaceutical company, has announced outstanding results for the third quarter of 2024, showcasing robust financial performance and significant progress in its innovative product pipeline.  The company's dedication to providing healthcare solutions for patients worldwide is reflected in its impressive double-digit sales growth and groundbreaking achievements in research and development.

Sanofi's Q3 2024 sales surged by 15.7% at constant exchange rates (CER), reaching €13,438 million. Business earnings per share (EPS) also saw a significant increase, rising by 12.2% on a reported basis and 17.6% at CER to reach €2.86. This strong performance was fueled by better-than-expected vaccine sales, particularly for influenza and Beyfortus (RSV), and the continued strong growth of Dupixent, the company's leading immunology drug.

Dupixent Continues its Impressive Growth Trajectory

SHERIDAN, WYOMING – November 8, 2024 – Sanofi, a global biopharmaceutical company, is taking a bold stance in the fight against cancer by launching a comprehensive program designed to support employees impacted by the disease. Recognizing the profound impact cancer can have on individuals and their families, Sanofi's "Cancer & Work: Acting Together" initiative provides a 360° approach to addressing the financial, emotional, social, and professional needs of its colleagues.

"We're creating an environment where everyone is supported to bring their best self to work," says a Sanofi spokesperson. This commitment is evidenced by Sanofi's participation in Publicis' #WorkingWithCancer global pledge, a public declaration to combat cancer and its associated stigmas in the workplace.

SHERIDAN, WYOMING – November 4, 2024 – SHERIDAN, WYOMING – November 4, 2024 – MEDICA 2024 is gearing up to be a major event for healthcare innovation, with a special focus on start-ups. The event, taking place in Düsseldorf from November 11-14, will feature two key competitions: the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION.

Global Innovation Takes Center Stage

The finalists for these competitions have been narrowed down from a pool of 550 candidates, representing 62 countries. These innovative teams will showcase their solutions on the MEDICA INNOVATION FORUM stage, highlighting breakthroughs in areas like AI, robotics, and mobile health.

The Intersection of AI and Healthcare

One of the key themes at MEDICA 2024 is the role of AI in healthcare. The event will feature discussions on topics such as:

SHERIDAN, WYOMING – October 30, 2024 – Taiwan is set to revolutionize the medical technology landscape at MEDICA 2024, presenting cutting-edge AI-powered surgical innovations alongside a comprehensive array of advanced medical devices. From November 11-14 at Messe Düsseldorf, 17 leading Taiwanese companies will unveil 28 groundbreaking products, positioning Taiwan at the forefront of global healthcare innovation. The event will kick off with a press conference titled "AI-Powered Surgeons: The Best Made in Taiwan" on November 11, spotlighting AI-assisted surgical systems, smart medical devices, and next-generation diagnostic tools that promise to redefine patient care and surgical precision.

Taiwan's Rise as a Global MedTech Powerhouse

SHERIDAN, WYOMING – October 30, 2024 – The Taiwan Excellence Pavilion showcased Taiwan's leading medical innovations and cutting-edge solutions at Medical Fair Asia 2024, held at Marina Bay Sands Expo and Convention Centre from September 11th to 13th.

Taiwan's Strong Presence at Medical Fair Asia 2024

Taiwan's representation at the event was significant, with about 90 companies participating in three separate Taiwan pavilions: Taiwan Excellence Pavilion, Taiwan Pavilion, and TMBIA Pavilion.

Themed "Shaping the Future with Taiwan's MedTech Innovation," the Taiwan Excellence Pavilion focused on three key aspects of Taiwan's medtech innovations: Diagnostic Innovations, Treatment Innovations, and Innovations in Telemedicine and Digital Health Platforms.

"Shaping the Future with Taiwan's MedTech Innovation"

SHERIDAN, WYOMING – October 21, 2024 – Applications are now open for permanent make-up artists to participate in the "Permanent Beauty Masters 2025" competition. This highly professional and independent PMU competition will be held on Saturday, March 29, 2025, at BEAUTY DÜSSELDORF, the leading event for beauty professionals in cosmetics, nails, lashes, pedicure, and wellness.

"Our Competition provides permanent make-up artists from all over the world with a unique stage for presenting their art in four demanding categories. I'm especially delighted to now have two nomination phases enabling us to encourage talents to present themselves at the biggest event of the industry," says Olga Hendricks from the OH-ACADEMY, which will again be in charge of the conceptual design of the Competition and the PMU lecture program.

Technical Precision and Artistic Skills

SHERIDAN, WYOMING – October 18, 2024 – SHERIDAN, WYOMING – October 18, 2024 – As the deadline for Unique Device Identification (UDI) compliance approaches, medical device manufacturers are seeking reliable solutions to meet the regulatory requirements. GS1 Germany, an accredited UDI issuing agency, offers comprehensive support and resources to help manufacturers navigate the complexities of UDI implementation.

What is Unique Device Identification (UDI)?

UDI is a globally unique, machine-readable identification system for medical devices and in-vitro diagnostics. It is mandated in Europe and the USA to enhance patient safety and facilitate the traceability of medical devices.

The Approaching Deadline

Starting May 26, 2025, all Class 1 medical devices that are not directly marked must have a UDI barcode on their labeling. This deadline applies to both manufacturers and distributors of medical devices.

SHERIDAN, WYOMING – November 14, 2021 –

The MEDICA 2021 event was a hub of innovation, showcasing groundbreaking health start-ups that are poised to transform the industry.

The event featured over 300 exhibitors from around the globe who presented inviground technologies and products. This year, the focus has been on digital health solutions, as companies aim to engineer their products with the latest technologies.

My Sample Innovations (MSI) became one of the hottest start-ups with its cut-organ device that monitors essential vitals for patients. "This device is a gamechanger for doctors," said Michael Roberts, CEO of MS. "Now we can detect and respond to any changes in real-time."